Miranda H. Meeuwsen

Leiden, ZH 2333ZA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Journal: Blood

Published: December 09, 2025

DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets.

DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets.

Journal: Molecular therapy. Oncology

Published: August 28, 2024

CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells.

CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 08, 2024

Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapy.

Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapy.

Journal: Molecular therapy oncolytics

Published: November 03, 2023

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.

Journal: Blood advances

Published: April 07, 2023

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.

Journal: Frontiers in immunology

Published: December 12, 2022

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.

Journal: Journal of hematology & oncology

Published: November 17, 2022

A library of cancer testis specific T cell receptors for T cell receptor gene therapy.

A library of cancer testis specific T cell receptors for T cell receptor gene therapy.

Journal: Molecular therapy oncolytics

Published: June 08, 2022

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure.

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure.

Journal: Oncoimmunology

Published: February 07, 2022

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.

Journal: Journal for immunotherapy of cancer

Published: February 02, 2022

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion.

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion.

Journal: Journal for immunotherapy of cancer

Published: January 28, 2022

Cutting Edge: Unconventional CD8+ T Cell Recognition of a Naturally Occurring HLA-A*02:01-Restricted 20mer Epitope.

Cutting Edge: Unconventional CD8+ T Cell Recognition of a Naturally Occurring HLA-A*02:01-Restricted 20mer Epitope.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: January 05, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026